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SUMMARY 
 
The Type VI secretion system (T6SS) is a multi-protein machine that delivers protein effectors in 
both prokaryotic and eukaryotic cells, allowing interbacterial competition and virulence. The 
mechanism of action of the T6SS requires the contraction of a sheath-like structure that propels a 
needle toward target cells, allowing the delivery of protein effectors. Here, we provide evidence that 
the entero-aggregative Escherichia coli Sci-1 T6SS is required to eliminate competitor bacteria. We 
further identify Tle1, a toxin effector encoded by this cluster and showed that Tle1 possesses 
phospholipase A1 and A2 activities required for the inter-bacterial competition. Self-protection of the 
attacker cell is secured by an outer membrane lipoprotein, Tli1, which binds Tle1 in a 1:1 
stoichiometric ratio with nanomolar affinity, and inhibits its phospholipase activity. Tle1 is delivered 
into the periplasm of the prey cells using the VgrG1 needle spike protein as carrier. Further analyses 
demonstrate that the C-terminal extension domain of VgrG1, including a transthyretin-like domain, is 
responsible for the interaction with Tle1 and its subsequent delivery into target cells. Based on these 
results, we propose an additional mechanism of transport of T6SS effectors in which cognate effectors 
are selected by specific motifs located at the C-terminus of VgrG proteins. 
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INTRODUCTION 
 
The T6SS is built by the assembly of at least 13 proteins encoded by usually clustered genes. 
A trans-membrane complex anchors to the cell envelope a phage-like tail complex that extends from 
the membrane in the cytoplasm (Coulthurst, 2013; Zoued et al., 2014; Ho et al., 2014; Basler, 2015). 
The membrane complex serves as docking station for assembly of the tail complex (Durand et al., 
2015), a dynamic tubular structure functionally and structurally homologous to the contractile tail of 
bacteriophages (Bönemann et al., 2009; Leiman et al., 2009; Bönemann et al., 2010; Basler et al., 
2012). It is constituted of an inner tube made of stacked hexameric rings of the Hcp protein, whose 
three-dimensional structure is very similar to that of the bacteriophage tail tube gpV (Mougous et al., 
2006; Pell et al., 2009; Ballister et al., 2008; Brunet et al., 2014; Douzi et al., 2014). This Hcp edifice 
resembles a channel-like tubular structure with a 40-Å internal diameter and is surrounded by a 
contractile sheath made of the TssB and TssC proteins (Kudryashev et al., 2015). The inner 
tube/sheath structure is built on an assembly platform – the baseplate – that contacts the membrane 
complex (Brunet et al., 2015). The TssBC sheath is highly dynamic. Cycles of sheath assembly, 
contraction and disassembly were visualized by time-lapse fluorescence microscopy using fluorescent 
TssB–sfGFP fusion constructs (Basler et al., 2012; Brunet et al., 2013; Kapitein et al., 2013). The 
inner tube is capped by the spike composed of a VgrG (valine glycine repeat protein) trimer. This 
complex is structurally homologous to the bacteriophage T4 gp27-gp5 cell-puncturing device 
(Leiman et al., 2009). The VgrG trimer global fold consists of a gp27-like trimer, followed by the N-
terminal OB fold domain of gp5 and a three-stranded β-helix that forms the needle of the spike 
complex. In some T6SSs, an additional component called PAAR (Pro-Ala-Ala-Arg motif-containing 
protein) assembles a conical structure at the tip of the VgrG protein (Shneider et al., 2013). This 
 4 
component was proposed to sharpen the VgrG spike, assist folding and to stabilize the β-helix domain 
of VgrG or to be used as an adaptor component mediating interaction between VgrG and effector 
proteins (Shneider et al., 2013). The contractile structure assembles in an elongated metastable state. 
Upon contact with a target cell, the sheath contraction is thought to propel the Hcp inner tube towards 
the target cell, piercing the membrane using the VgrG/PAAR spike complex, hence leading to 
effector delivery (Cascales, 2008; Silverman et al., 2012; Coulthurst, 2013; Ho et al., 2014; Zoued et 
al., 2014). In agreement with this mechanism of action, time-lapse fluorescence recordings 
demonstrated that contraction of the sheath is correlated with lysis of the prey cell (Brunet et al., 
2013).  
 The T6SS is a versatile machinery as it has been shown to have roles in both pathogenesis and 
inter-bacterial competition, and effectors that have eukaryotic or prokaryotic targets have been 
identified and characterized (Russell et al., 2014; Durand et al., 2014, Alcoforado Diniz et al., 2015). 
For examples, the Vibrio cholerae and Aeromonas hydrophila T6SSs disable eukaryotic cells by 
delivering specific effector modules that interfere with the actin cytoskeleton dynamics (Pukatzki et 
al., 2006; Pukatzki et al., 2007; Suarez et al., 2010; Durand et al., 2012) while a growing number of 
T6SSs have been demonstrated to have anti-bacterial activities (Hood et al., 2010; Schwarz et al., 
2010; MacIntyre et al., 2010; Murdoch et al., 2011; Gueguen et al., 2013; Brunet et al., 2013; 
Carruthers et al., 2013). In fact, bacteria do not live alone in their environment: they share the same 
ecological niche, socialize, but also display antagonistic behaviours and compete with each other. The 
T6SS is one of the key players during the bacterial warfare by delivering anti-bacterial effectors 
directly into bacterial competitor cells (Coulthurst, 2013; Ho et al., 2014; Durand et al., 2014, 
Alcoforado Diniz et al., 2015). Among these effectors, the Tae (type VI secretion amidase effector) 
and Tge (type VI secretion glycoside hydrolase effector) effectors degrade the peptidoglycan of the 
target cells, the Tle (type VI lipase effectors) toxins hydrolyse the membrane phospholipids of the 
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target cells whereas the Tde (type VI DNase effectors) are nucleases (Russell et al., 2014; Benz and 
Meinhart, 2014; Durand et al., 2014). Recently, the P. aeruginosa Tse6 T6SS effector has been 
demonstrated to have NAD(P)+ glycohydrolase activity, hence depleting the NAD(P)+ pool of the 
target cell (Whitney et al., 2015). The cell wall degrading effectors target the peptide stem (Tae) or 
the glycan strands (Tge) of the peptidoglycan and can be divided in several families with different 
hydrolysed bond specificities (Russell et al., 2014; Benz and Meinhart, 2014; Durand et al., 2014). 
Tle toxins consist to a large group of enzymes that could be divided into five divergent families 
bearing phospholipase A1, A2 or D activities (Russel et al., 2013). Interestingly, whereas the Tae and 
Tge toxins are anti-bacterial only, members of the Tle or Tde toxin families target macromolecules 
present in both eukaryotic and prokaryotic cells. Indeed, a number of Tle toxins have been shown to 
cause damages in eukaryotic cells, such as the P. aeruginosa PldB (Tle5bPA) protein that promotes 
invasion of eukaryotic cells by activation of the AKT/PI3pathway (Jiang et al., 2013) or the Tle2VC 
toxin that is necessary for V. cholerae to escape amoeba predation (Dong et al., 2013).  
To prevent self-intoxication, Tae, Tge, Tle and Tde anti-bacterial effectors are produced 
concomitantly with cognate immunity proteins, called Tai, Tgi, Tli and Tdi, respectively (Russell et 
al., 2014; Benz and Meinhart, 2014; Durand et al., 2014). Usually, the immunity protein resides in the 
compartment in which the toxin is delivered, binds to the toxin with high (nanomolar) affinity and 
inhibits it, either by the occlusion of the catalytic site or by preventing access to its target (Russell et 
al., 2014; Benz and Meinhart, 2014; Durand et al., 2014).  
 T6SS toxins exist either as independent proteins or additional modules fused to the Hcp, VgrG 
or PAAR components. These effector modules are hence delivered into the target cell upon sheath 
contraction. The cargo mechanisms by which independent effectors are delivered into the target cell is 
less known. The current transport models propose that these effectors bind to the Hcp, VgrG or 
PAAR proteins directly or via adaptor proteins, and therefore that these structural components of the 
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machine are used as carriers (Silverman et al., 2013; Shneider et al., 2013; Hachani et al., 2014; 
Durand et al., 2014). Indeed, the P. aeruginosa Tae1 and Tge1 effectors are embedded into the lumen 
of the Hcp ring and are stored into the Hcp inner tube before sheath contraction (Silverman et al., 
2013). It has been suggested that several P. aeruginosa effectors bind directly or indirectly to VgrG 
(Dong et al., 2013; Whitney et al., 2014; Hachani et al., 2014). Hachani et al. suggested that 
VgrG/effector combinations are not interchangeable and that selection of the effector depends on 
specific motifs on VgrG (Hachani et al., 2014). More recently, conserved T6SS adaptor proteins 
linking VgrG and cognate effectors were identified (Alcoforado Diniz and Coulthurst, 2015; 
Unterweger et al., 2015; Liang et al., 2015).   
 In the recent years we have characterized the regulatory mechanisms and the structural 
architecture of the entero-aggregative E. coli (EAEC) Sci-1 Type VI secretion system (T6SS-1). 
However, the function of this T6SS has remained elusive and no T6SS-1 substrate has been identified. 
The EAEC sci-1 gene cluster encodes the 13 core components, a PAAR protein, the TagL accessory 
protein, and 6 genes of unknown function. Among these genes, a gene encoding a putative Tle1 
effector followed by a gene encoding a putative lipoprotein is found downstream vgrG1. In this study, 
we demonstrate that the Sci-1 T6SS is required for EAEC antibacterial activity in minimal medium 
and that Tle1EAEC possesses phospholipase A1 (PLA1) and A2 (PLA2) activities responsible for the 
antibacterial activity of Sci-1 T6SS. We then show that Tli1EAEC is an outer membrane immunity 
lipoprotein that binds tightly to Tle1EAEC and inhibits its PLA activity. Finally, we demonstrate that 
Tle1EAEC is a cargo effector and is delivered into target cells using the VgrG1 spike as carrier through 
direct interaction with the VgrG1 C-terminal extension. 
 
 
 
 7 
Results 
 
The EAEC T6SS sci-1 gene cluster has anti-bacterial activity in minimal medium. 
To gain insights into the function of the Sci-1 T6SS, we compared the EAEC 17-2 wild-type 
(WT) strain with its derivative strain deleted of the entire sci-1 gene cluster (∆T6SS-1) for (i) 
virulence towards eukaryotic cells using the Cænorhabditis elegans model of infection and (ii) 
antagonism against competitor bacteria. The experiments were performed in NGM or sci-1 inducing 
minimal media (SIM) to allow maximal expression of the sci-1 gene cluster (Brunet et al., 2011). In 
these conditions, the growth rates of the WT strain and its isogenic ∆T6SS-1 mutant were comparable 
(data not shown). 
In C. elegans, the WT EAEC 17-2 cells were moderately virulent, with a lethal dose 50% 
(LD50) of 7 days (compared to 3 days for Burkholderia cenocepacia K56-2). Identical values were 
obtained when ∆T6SS-1 cells were used as feeding source for the worms (Fig. 1A). These data 
suggest that the T6SS-1 is not involved in the virulence of EAEC 17-2 in the C. elegans model of 
infection. The anti-bacterial activity was therefore tested in SIM. The E. coli K-12 strain W3110 
(devoid of T6SS genes) engineered to constitutively produce the green fluorescent protein (GFP) and 
to resist kanamycin was used as prey. Attacker and prey cells were mixed in a 4:1 ratio and the 
mixtures were spotted on SIM agar plates. After a 4-hour incubation at 37°C, the fluorescence levels 
and the number of kanamycin-resistant colony-forming units (cfu) were measured to estimate the 
survival of the prey cells (Fig. 1B). In these conditions, the deletion of the sci-1 gene cluster increased 
the recovery of prey cells. We therefore concluded that the T6SS-1 machine provides anti-bacterial 
activity in minimal medium.  
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The EC042_4534 gene product encodes an anti-bacterial effector with phospholipase A1 and A2 
activities. 
To identify potential effector toxins, we screened the sci-1 gene cluster. The sci-1 gene cluster 
encodes the 13 T6SS core-components, PAAR and a number of genes of unknown function (Fig 2A). 
Among those, a group of three genes, EC042_4534, EC042_4535 and EC042_4536 is found between 
the vgrG1 (EC042_4533) and PAAR (EC042_4537) genes. EC042_4534 (NCBI Gene Identifier (GI): 
284924255) is encoded directly downstream vgrG1. Computer analysis of the EC042_4534 gene 
product using Pfam predicts it carries a DUF2235 domain (uncharacterized α/β hydrolase domain, 
amino-acid 36 to 333, E-value 9.7 e-24). A phylogenetic reconstruction of EC042_4534 with 
members of Type VI lipase effector (Tle) families 1 to 5 (as defined by Russell et al., 2013) showed 
that EC042_4534 segregates with Tle1 members (Fig. S4). Multiple alignments of EC042_4534 with 
Tle1 members revealed the characteristic GXSXG motif usually found in lipases and some 
phospholipases (Fig. S5). Fold recognition servers (such as Phyre2, Kelley and Sternberg, 2009) 
suggest significant homologies between EC042_4534 and the D1 catalytic domain of the 
Pseudomonas aeruginosa Tle1PA protein (Hu et al., 2014; data not shown). The structure of 
EC042_4534 was modelled using the structure of Tle1PA (Protein Data Bank (PDB) identifier 4O5P, 
Hu et al., 2014) as template (Fig 2B). As expected, the structural model predicts that the catalytic 
triad is composed of the Ser-197, Asp-245 and His-310 amino acids (Fig. 2B). EC042_4534 protein is 
thus a putative member of the Tle1 family of T6SS effectors and was therefore named hereafter 
Tle1EAEC. 
In order to biochemically characterize Tle1EAEC, its coding sequence was cloned into the 
pETG20A E. coli expression vector, fused to a N-terminal hexahistidine-tagged thioredoxin domain 
followed by a Tobacco Etch Virus (TEV) cleavage site. The wild-type Tle1EAEC protein 
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(Tle1EAEC(WT)) and a variant bearing a mutation in the putative catalytic triad (Tle1EAEC(S197A)) were 
purified to homogeneity using ion metal affinity chromatography and gel filtration, and the 
recombinant Tle1EAEC(WT) and Tle1EAEC(S197A) proteins were obtained upon cleavage using the TEV 
protease (see inset in Fig. 2C). Since the two Tle1 family members characterized so far, B. 
thailandensis Tle1BT and Tle1PA, have phospholipase A2 (PLA2) activity (Russell et al, 2013; Hu et 
al., 2014), the activity of the purified Tle1EAEC and Tle1EAEC(S197A) were tested on fluorogenic 
phospholipid substrates (Fig. 2C). Tle1EAEC possesses both phospholipase A1 (PLA1) activity (specific 
activity (SA) = 1338 pmole.min-1.mg-1) and a 12.5 lower PLA2 activity (SA = 107 pmole.min-1.mg-1). 
By contrast, the purified Tle1 protein has undetectable phospholipase C and triacylglycerol lipase 
activities (data not shown). The PLA1 and PLA2 activities were abolished when the putative catalytic 
Ser-197 residue was substituted by an alanine (S197A mutant) (Fig. 2C). Finally, to gain insight into 
Tle1EAEC specificity, the rate of hydrolysis of major lipids of bacterial membranes 
phosphatidylethanolamine (DLPE) and phosphatidylglycerol (DLPG), as well as phosphatidylcholine 
(DLPC) and phosphatidylserine (DLPS), was tested on monolayer films (Table 1). Tle1EAEC – but not 
its S197A mutant – shows a slight activity on DLPC, DLPE and DLPS while DLPG hydrolysis was 
undetectable. Based on bioinformatic analyses and biochemical results, we conclude that the 
EC042_4534 protein is a member of the Tle1 family of T6SS effectors having PLA1/PLA2 activity. 
In order to test whether Tle1EAEC was involved in the anti-bacterial activity of the Sci-1 T6SS, 
we constructed a tle1 deletion mutant strain. Due to technical genetic constraints (see Experimental 
Procedures), this strain is also deleted of the following tli1 gene (that encodes its cognate immunity, 
see below). The Hcp release assay, which reflects proper assembly and function of the T6SS, 
demonstrated that Tle1 (and Tli1) is not necessary for T6SS assembly and function (Fig S1). However, 
as shown in Fig. 2D, the absence of Tle1 and Tli1 decreased the anti-bacterial activity of EAEC 
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against E. coli K-12 cells to the same extent as the T6SS-1 deletion mutant. The anti-bacterial activity 
was restored by the trans-expression of wild-type tle1, but not with that of tle1S197A (Fig. 2D). 
Therefore these results suggest that the anti-bacterial toxicity of the sci-1 T6SS gene cluster towards E. 
coli is conferred by the phospholipase activity of Tle1EAEC. 
 
Tli1EAEC (EC042_4535) assures self-protection by inhibiting Tle1EAEC phospholipase activity. 
In T6SS, protection against kin cells is secured by the production of immunity proteins that 
specifically bind and inhibit their cognate toxins. Usually, effector/immunity genes are found in 
tandem in genomes. In the sci-1 gene cluster, the tle1EAEC gene is followed by a duplicated region 
encoding two putative immunity proteins: EC042_4535 and EC042_4536 (GIs: 284924256 and 
284924257 respectively). In the sequenced 042 strain, the 225-amino-acid EC042_4535 and 
EC042_4536 proteins only differ by a few residues at their extreme C-termini (Fig. S2A). However, 
in the 17-2 strain used in this study, the EC042_4536 gene has a frameshift mutation at nucleotide 
386 that yields a 154-amino-acid truncated protein (Fig. S2A and S2B) that was not further analysed. 
To test if the product of the EC042_4535 gene assures protection against Tle1EAEC, the EC042_4535 
gene was expressed from the pBAD18 vector in W3110 gfp+ reporter prey cells. Anti-bacterial 
competition experiments showed that the production of EC042_4535 in the E. coli K-12 prey 
conferred full protection against the anti-bacterial activity of the Sci-1 T6SS (Fig. 3A). In addition to 
showing that EC042_4535 confers protection, this result also demonstrates that Tle1EAEC is delivered 
into target cells and suggests that Tle1EAEC is the major anti-bacterial Sci-1 T6SS effector in these 
conditions. In agreement with this result, when used as prey, the ∆EC042_4535-4536 mutant was 
killed by the wild-type EAEC but not by the ∆T6SS-1 or the tle1-tli1 deletion mutant strain (Fig. 3B). 
Finally, production of EC042_4535 in ∆EC042_4535-4536 prey cells protected them against EAEC 
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killing. It is worthy to note that the recovered fluorescence of complemented ∆EC042_4535-4536 
cells is higher than in non complemented cells, likely due to the sickness of the ∆EC042_4535-4536 
prey cells (Fig. 3B). To confirm this result biochemically, the EC042_4535 protein was purified to 
homogeneity and tested for its ability to interfere with the Tle1EAEC activity. Fig. 3C and Table 1 
show that the Tle1EAEC phospholipase activity was inhibited by EC042_4535 in a dose-dependent 
manner. Interestingly, the Tle1EAEC activity was completely abolished with a Tle1EAEC:EC042_4535 
molecular ratio of 1:1 (Fig 3C), which is the highest ratio that can be expected between an enzyme 
and a specific inhibitor. Taken together, these results confirm that EC042_4535 is an immunity 
protein that protects against the phospholipase activity of Tle1EAEC, and therefore EC042_4535 was 
named Tli1EAEC. 
 
Tli1EAEC-dependent Tle1EAEC inhibition is mediated by tight binding of Tli1EAEC to Tle1EAEC.   
The Tli1EAEC-mediated inhibition of Tle1EAEC activity strongly suggests that Tli1EAEC binds to 
Tle1EAEC. To test this hypothesis, we first performed a bacterial two-hybrid (BACTH) assay. The 
Tle1EAEC coding sequence was cloned downstream the T18 or T25 domains of the Bordetella 
adenylate cyclase, whereas the Tli1EAEC coding sequence (deleted of its lipoprotein signal sequence) 
was cloned upstream the T18 and T25 domains. When the Tle1EAEC and Tli1EAEC fusion proteins were 
co-produced, the expression of the reporter gene was activated demonstrating that Tli1EAEC and 
Tle1EAEC interact (Fig. 4A). The BACTH assay also suggested that Tle1EAEC and Tli1EAEC are 
monomeric as no Tle1-Tle1 or Tli1-Tli1 interactions were detected (Fig. 4A). To validate these 
results by alternative approaches, the purified Tle1EAEC and Tli1EAEC proteins, and the mixture of the 
two purified proteins, were subjected to gel filtration and on-line multi-angle laser light 
scattering/quasi-elastic light scattering/absorbance/refractive index (MALS/QELS/UV/RI). Size 
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exclusion chromatography demonstrated that Tle1EAEC and Tli1EAEC have apparent molecular masses 
of 66 kDa and 23.9 kDa, respectively (Fig. 4B). These values, in agreement with their theoretical 
molecular weights of 62.3 and 24 kDa, further indicate that these proteins are monomeric in solution. 
Analysis of the Tle1EAEC/Tli1EAEC mixture showed the apparition of an additional peak containing 
both proteins (peak 1, Fig. 4B), demonstrating complex formation between the two proteins in vitro. 
With an apparent molecular mass of ~ 82 kDa, this complex likely corresponds to a Tle1EAEC-Tli1EAEC 
heterodimer (calculated molecular weight: 86 kDa). Analyses of purified Tle1EAEC, Tli1EAEC and 
Tle1EAEC-Tli1EAEC complex by MALS/QELS/UV/RI confirmed that both Tle1EAEC and Tli1EAEC are 
monomeric and that the Tle1EAEC-Tli1EAEC complex has a 1:1 stoichiometry (Fig. 4C). To determine 
the strength of the Tle1EAEC-Tli1EAEC interaction, the association of the two partners was monitored by 
Biolayer Interferometry (BLI). The Tli1EAEC protein was biotinylated, coupled to a streptavidin 
sensortip and the association and dissociation of Tle1EAEC were recorded for 600 sec. and 1,800 sec. 
respectively (Fig. 4D). Based on the curve fitting and assuming a 1:1 Tle1EAEC:Tli1EAEC heterodimer, 
Tle1EAEC and Tli1EAEC associates with a KD constant value of 1.5 ±0.05 nM. The Kon and Koff values 
(Kon=1.65×105 M-1s-1 and Koff=2.2×10-4 s-1) are in agreement with a rapid association of the two 
proteins, but a slow dissociation of the complex. Taken together, these results demonstrate that 
Tle1EAEC and Tli1EAEC are monomeric in solution and interact to form a stable 1:1 heterodimer with 
nanomolar affinity. 
 
Tli1EAEC is an outer membrane lipoprotein protecting against delivery of cytoplasmic Tle1EAEC 
in the periplasm of target cells.  
The tle1EAEC gene is predicted to encode a 62.3-kDa cytoplasmic protein, with no predicted 
signal peptide or trans-membrane segment. Fractionation of EAEC cells producing Tle1EAEC fused to 
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a C-terminal VSVG epitope (Tle1VSVG) showed that Tle1EAEC co-localizes with the EF-Tu cytoplamic 
marker hence confirming its cytoplasmic localization (Fig. 5A). Tle1VSVG was not detected in the 
supernatant fraction (data not shown). By contrast, the tli1EAEC gene is predicted to encode a protein 
with a signal sequence bearing a characteristic lipobox motif, such as other Tli1 homologues (Fig. 5B). 
In agreement with this prediction, Tli1EAEC processing was inhibited by the signal peptidase II (SPII) 
inhibitor globomycin (Fig. 5C). In Gram-negative bacteria, lipoprotein sorting is controlled by the Lol 
complex and the final localization of the lipoprotein follows the “+2 rule”, i.e., depends on the residue 
immediately downstream the acylated cysteine (Zückert, 2014). In Tli1EAEC, the +2 residue is an 
asparagine suggesting an outer membrane destination (Fig. 5B). To determine its sub-cellular 
localization, total membranes of tli1EAEC cells producing a functional C-terminally FLAG-tagged 
Tli1EAEC protein (Tli1FL) were subjected to sedimentation density sucrose gradient separation. By 
comparison with the behaviour of control proteins in the sucrose gradient (the outer membrane porin 
OmpF and the inner membrane NADH oxidase), we concluded that Tli1EAEC co-fractionates with 
outer membrane proteins (Fig. 5D). Taken together these experiments defined that Tle1EAEC is a 
cytoplasmic protein whereas Tli1EAEC is an outer membrane lipoprotein.  
To explain the interaction between Tle1EAEC and Tli1EAEC despite their different localization, 
we predicted that Tle1EAEC should be delivered into the periplasm of the target cell, and thus be a 
periplasmic-acting toxin. To test this hypothesis, we tested the effects of the heterologous production 
of Tle1EAEC in the cytoplasm or periplasm of E. coli K-12. Tle1EAEC was readily produced in the 
cytoplasm of E. coli without any toxic effect (Fig. 6A). By constrast, we did not succeed to construct 
a vector allowing the artificial periplasmic production of Tle1EAEC by fusing the tle1EAEC-coding 
sequence downstream the ompA signal sequence (sp-Tle1EAEC). The construction was only obtained 
when the cloning steps were performed in cells producing Tli1EAEC from the pBAD33 vector in the 
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presence of arabinose. Indeed, periplasmic targeting of Tle1EAEC is highly toxic in the absence of 
arabinose (Fig. 6B). The sp-Tle1EAEC toxicity is efficiently counteracted by the co-production of 
Tli1EAEC. In agreement with the in vitro and in vivo studies (Fig. 2C and 2D), the periplasmic 
production of the Tle1EAEC catalytic mutant Tle1S197A had roughly no effect on cell viability (Fig. 6B), 
confirming that Tle1EAEC bacterial toxicity is conferred by its catalytic activity. 
 
Tle1EAEC interacts with the VgrG1 C-terminal extension. 
The cargo model proposes that independent effectors are secreted through direct or indirect 
(via adaptor proteins) interactions with VgrG, Hcp or PAAR protein components (Silverman et al., 
2013; Shneider et al., 2013; Whitney et al., 2014; Hachani et al., 2014; Durand et al., 2014; 
Alcoforado Diniz and Coulthurst, 2015; Unterweger et al., 2015; Liang et al., 2015). Bioinformatic 
analyses of sci-1 genes of unknown function showed that no putative adaptor protein is encoded in 
this cluster. To gain insights into the secretion mechanism of Tle1EAEC, we therefore tested direct pair-
wise interactions between Tle1EAEC and the sci-1-encoded Hcp1, VgrG1, and PAAR proteins by 
bacterial two-hybrid. Tle1EAEC was fused downstream or upstream the T25 domain whereas the Hcp1, 
VgrG1 and PAAR proteins were fused to the T18 domain. The results presented in Fig. 7A indicate 
that Tle1EAEC interacts directly with VgrG1, but not with the Hcp1 or PAAR proteins. The Tle1 EAEC -
VgrG1 interaction could not be detected with the T25-Tle1 fusion protein suggesting fusion to the N-
terminus of Tle1EAEC may causes a steric hindrance preventing complex formation. To validate these 
data biochemically, we tested the VgrG1-Tle1EAEC interaction using a co-immunoprecipitation assay. 
To visualize direct interactions, the two proteins were produced into the E. coli K-12 heterologous 
host. Western-blot analyses of the eluted material showed that VSVG-tagged Tle1EAEC specifically co-
immunoprecipitated with FLAG-tagged VgrG1, but not with Hcp1FLAG (Fig. 7B and Fig. S3). Taken 
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together, the BACTH and co-immunoprecipitation assays demonstrate that Tle1EAEC interacts with 
VgrG1.  
Computer predictions and structural characterization of VgrG proteins showed that these 
proteins resemble the gp27-gp5 spike of bacteriophages (Pukatzki et al., 2007; Leiman et al., 2009). 
In EAEC, VgrG1 carries an additional C-terminal domain (CTD) separated from the gp27-gp5 
common core by a predicted coiled-coil region (Fig. 7C). To assess the importance of this domain for 
the VgrG1-Tle1EAEC interaction we constructed VgrG truncated derivatives lacking this region 
(VgrG1-615 lacking the CTD and VgrG1-573 lacking both CTD and the predicted coiled-coil region). Co-
immunoprecipitation and BACTH analyses showed that these truncations abolish Tle1EAEC binding, 
suggesting that the VgrG1 C-terminal domain is necessary for the VgrG1-Tle1EAEC interaction (Fig. 
7B and 7D). Furthermore, this domain alone is sufficient to mediate the interaction with Tle1EAEC, as 
shown by co-immunoprecipitation and BACTH experiments using the VgrG574-841 and VgrG616-841 
derivatives (Fig. 7B and 7D). The VgrG1 CTD possesses a domain of unknown function of the 
DUF2345 family (amino-acid 609-765). DUF2345 domains are commonly found associated with 
T6SS VgrG proteins (Boyer et al., 2009). Further bioinformatic analyses of this CTD using fold 
recognition servers such as Phyre2 and HHPred predicted that VgrG1 CTD amino-acid 611-766 
region is constituted of a regular repetition of small short-strands that are reminiscent to the C-
terminal domain of gp5 and likely extends the VgrG spike. This additional β-prism domain is 
followed by a 62-amino-acid region (residues 780 to 841) predicted to fold as a transthyretin (TTR)-
like domain. To test the contribution of this domain to the VgrG1-Tle1EAEC interaction, we 
constructed a VgrG1 truncated variant lacking the TTR-like region (VgrG1-778). Fig. 7D shows that 
VgrG1-778 interaction with Tle1EAEC is undectable by BATCH analysis. However, VgrG1-778 weakly 
interacts with Tle1EAEC using the co-immunoprecipitation assay (Fig. 7B) suggesting that the absence 
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of the TTR domain strongly affects but not completely abolishes the interaction with Tle1EAEC. 
Further BACTH experiments suggest that this domain is sufficient to mediate the interaction with 
Tle1EAEC as the VgrG771-841/Tle1EAEC combination activates the expression of the reporter gene (Fig. 
7D). Attempts to confirm by co-immunoprecipitation that the TTR domain of VgrG1 is sufficient for 
this interaction was unsuccessful, as this truncated variant was undectable by Western blot (data not 
shown). Collectively, these results show (i) that the VgrG1 CTD  is necessary and sufficient for the 
interaction with Tle1EAEC, (ii) that the TTR domain of VgrG1 CTD is involved in the interaction but 
(iii) that a second interaction motif located within the 615-778 DUF2345 region stabilizes the VgrG1-
Tle1 interaction.  
To further test the importance of these interaction motifs for the delivery of Tle1EAEC, we 
tested the ability of the VgrG1 C-terminal truncated derivatives to complement a vgrG1 knock-out 
mutant in Hcp secretion and killing assays (Fig. 8). The co-production of full length VgrG1 and Tle1 
complemented the killing defect of the vgrG knock-out strain (Fig. 8A). By constrast, production of 
the truncated VgrG1-615 or VgrG1-778 variants (with or without the co-production of Tle1) did not 
restore killing (Fig. 8A). However, this result is not due to the assembly of a non-functional T6S 
apparatus as deletion of the VgrG1 CTD did not affect Hcp release (Fig. 8B). Taken together, these 
results showed that deletion of the Tle1-binding motif within VgrG1 does not impair T6SS assembly 
but abolishes killing of prey cells, hence supporting the idea that Tle1 interaction with the C-terminal 
extension of VgrG is required for Tle1 export into target cells. 
 
Discussion 
In this study we show that the EAEC Sci-1 T6SS is required for inter-bacterial competition 
and report the full characterization of EC042_4534, the first T6SS toxin to be identified in EAEC, and 
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EC042_4535, its cognate immunity protein. We demonstrate that EC042_4534 has phospholipase A 
activity, belongs to family 1 of the T6SS lipase effectors (Russell et al., 2013), and was therefore 
named Tle1EAEC. A number of Tle proteins, delivered by the T6SS have been recently identified on 
the basis of their vicinity to vgrG genes. They consist of different enzymes divided into five divergent 
families (Russel et al., 2013). Tle families 1-4 contain a characteristic GXSXG esterase motif found 
in lipases and some phospholipases. In vitro studies have shown that the Burkholderia thailandensis 
Tle1BT and P. aeruginosa Tle1PA effectors have PLA2 activity (Russel et al., 2013; Hu et al., 2014). 
By contrast, the Vibrio cholerae Tle2VC toxin carries PLA1 activity (Russel et al., 2013). No 
enzymatic activity has been assigned so far for members of the Tle3 and Tle4 families. Tle5 family 
members contain a duplicated HXDXXXXG motif characteristic of phospholipase D (PLD) 
superfamily, and can be divided in two subfamilies (Tle5a and Tle5b), with Tle5a being eukaryotic-
like PLD (Russel et al., 2013; Jiang et al., 2014; Egan et al., 2015; Spencer and Brown, 2015). The 
PLD activities of P. aeruginosa Tle5aPA (known as PldA) and Tle5bPA (known as PldB) have been 
demonstrated (Russel et al., 2013; Jiang et al., 2014, Spencer and Brown, 2015), while Klebsiella 
pneumoniae Tle5bKP T6SS toxin presents a cardiolipin synthase activity (Lery et al., 2014).  
 
Our analyses showed that Tle1EAEC has PLA1 and to a lesser extent PLA2 activity, which 
contrasts with the previously characterized Tle1 members, Tle1BT and Tle1PA, which have PLA2 
activity only (Russel et al., 2013; Hu et al., 2014). It is noteworthy that the Tle classification was built 
on their protein sequences and phylogenetic distribution, and not on their activity. It remains possible 
that Tle1 members may not have all the same selectivity for the sn-1 and sn-2 positions. Tle1 toxins 
consist to very heterologous proteins in terms of size (~ 500-900 residues). They all possess a 
DUF2235 (α/β hydrolase fold domain) likely forming the catalytic module but bear distinct additional 
domains. For example, Tle1PA has a putative C-terminal membrane-anchoring module (Hu et al., 
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2014) that has been shown to be critical for the catalytic activity, suggesting that the activity of Tle1 
proteins might also be regulated by these additional domains. Further biochemical and structural 
characterizations of Tle1EAEC and other Tle1 proteins are therefore required to better understand the 
differences in substrate selectivity on the phospholipid sn-1 and sn-2 moieties. 
 
Our results also showed that Tle1EAEC is required for the anti-bacterial activity conferred by 
the Sci-1 T6SS. Tle1BT and Tle4APEC were previously shown to be required for the anti-bacterial 
activity of B. thailandensis and avian pathogenic Escherichia coli, respectively (Russel et al., 2013; 
Ma et al., 2014). By contrast, Tle5aPA (PldA) and Tle5bPA (PldB) are required for both bacterial 
competition and virulence (Jiang et al., 2014). Tle5bPA delivery into eukaryotic host cells promotes 
invasion through the activation of the AKT/PI3pathway (Jiang et al., 2014). Similarly, the Tle2VC 
toxin is necessary for the anti-bacterial activity of V. cholerae and its ability to escape amoeba 
predation (Dong et al., 2013). In K. pneumonia, Tle5KP is required for full virulence in a mouse model 
of infection (Lery et al., 2014). Although we did not observe any effect of the Sci-1 T6SS on C. 
elegans viability, we cannot rule out that the Tle1EAEC toxin might be delivered into eukaryotic host 
cells to create damages. It would be interesting to test the role of the Sci-1 T6SS and of its specific 
Tle1EAEC toxin on epithelial intestinal cells.  
 
Our results also demonstrated that the production of Tle1EAEC in the cytoplasm of E. coli K-12 
has no effect on its viability. By contrast, cells do not survive when Tle1EAEC is exported to the 
periplasm. This result is consistent with the observations that the heterologous periplasmic production 
of Tle1PA, Tle5aPA and Tle5bPA is toxic (Jiang et al., 2014; Hu et al., 2014). One may hypothesize that 
(i) Tle1EAEC targets specific lipids found in the outer leaflet of the inner membrane or in the inner 
leaflet of the outer membrane and/or (ii) that dedicated periplasmic proteins are required to activate 
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Tle1EAEC, as previously shown for the colicin M toxin (Hullmann et al., 2008). The activity of Tle 
toxins in the periplasm is in agreement with the synthesis of a cognate immunity protein called Tli 
that are usually periplasmic soluble proteins or membrane-anchored lipoprotein (Russel et al., 2013). 
In this work, we have shown that Tli1EAEC (EC042_4535) confers protection against Tle1EAEC. 
Fractionation, isopycnic centrifugation and processing inhibition assays demonstrated that Tli1EAEC is 
an outer membrane lipoprotein. Tli1EAEC-mediated inhibition of Tle1EAEC occurs by protein-protein 
contacts and is very efficient, as a molecular ratio of 1:1 totally abolishes Tle1EAEC phospholipase 
activity. The interaction between the two partners was observed in vivo by bacterial two-hybrid 
analyses and biochemical approaches. Other immunities to phospholipases characterized so far have 
been shown to inhibit the action of the effector by direct protein-protein contacts, such as the P. 
aeruginosa Tle5/Tli5 pairs (Russell et al., 2013; Jiang et al., 2014). In vitro analyses of the purified 
Tle1EAEC/Tli1EAEC complex by gel filtration, MALS/QELS/UV/RI and biolayer interferometry 
collectively demonstrated that Tle1EAEC interacts with Tli1EAEC with a 1:1 stoichiometry and a KD of 
1.5 nM. This tight binding, with a very fast association and a very slow dissociation is in accordance 
with the role of Tli1EAEC as a specific immunity protein, as the control of Tle1EAEC activity should be 
strict among bacteria from the same species and should occur rapidly after delivery of Tle1EAEC. This 
nanomolar affinity is in the same range as other T6SS effector/immunity pairs such as Tae1/Tai1 
couples (Ding et al., 2012; Shang et al., 2012) and suggests an extensive surface of contact between 
the two partners. Indeed, the crystal structure of the putative P. aeruginosa Tle4 effector in complex 
with its putative immunity protein (Tli4PA) revealed that Tli4PA covers a surface area of ~ 2,800 Å2 
and use a grasp mechanism to prevent the interfacial activation of Tle4PA (Lu et al., 2014). Further 
structural characterization of the EAEC Tle1/Tli1 complex is required to better understand the 
molecular bases for this efficient inhibition. 
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In this work, we also addressed the secretion mechanism of Tle1EAEC. Several mechanisms 
have been identified or proposed for independent effectors, and all of them involve direct or indirect 
contacts with the Hcp rings, the VgrG spike or the PAAR protein that sits on VgrG (Silverman et al., 
2013; Shneider et al., 2013; Whitney et al., 2014; Hachani et al., 2014; Durand et al., 2014). Recently, 
conserved adaptor proteins of the DUF4123 family interacting with both VgrG and the effector were 
shown to be required for the translocation of a number of T6SS effectors (Liang et al., 2015; 
Unterweger et al., 2015). Here, co-immunoprecipitation and bacterial two-hybrid analyses 
demonstrated that Tle1EAEC interacts directly with VgrG1 and that this interaction is required for 
proper Tle1EAEC delivery. A gene encoding a putative PAAR protein, EC042_4537, is found 
immediately downstream Tli1. However, PAAR is not required for the VgrG1/Tle1EAEC direct 
interaction, suggesting that it constitutes a structural element at the tip of the VgrG spike or that it is 
involved in the recruitment and transport of a yet unidentified effector. In the cargo transport 
hypothesis, the VgrG proteins are used as carriers to deliver effectors into the target cell (Durand et 
al., 2014). In P. aeruginosa, several toxins have been shown to be dependent on dedicated VgrG 
proteins for their delivery suggesting that VgrG proteins bear specific sequences to select cognate 
effectors (Whitney et al., 2014; Hachani et al., 2014). Our results support this idea as we found that 
the C-terminal extension of VgrG1 is necessary and sufficient to mediate binding to and transport of 
Tle1EAEC. Particularly, we identified a region of 62 amino-acids at the C-terminus of VgrG1 involved 
in this interaction. This short domain is predicted to fold as a transthyretin-like (TTR) domain. TTR 
domains are putative protein-protein interaction modules. Interestingly, TTR domains were 
previously identified as PAAR protein extensions, and were proposed to be adaptors to mediate 
interaction with effector proteins (Shneider et al., 2013). However, deletion of the TTR domain of 
VgrG1 did not totally abolish the interaction with Tle1EAEC, suggesting that another motif may be 
present in the DUF2345 domain of VgrG1. Collectively, these results demonstrate that 
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DUF2345/TTR domains are involved in selection and transport of T6SS effectors. One may 
hypothesize that distinct motifs should be involved in the recruitment of effectors to confer specificity. 
Indeed, although this needs to be experimentally verified, a disordered loop within the C-terminal β-
helix of the E. coli O157 VgrG1 protein was proposed to be an interaction site with effectors (Uchida 
et al., 2014). Similarly, the recent release of the structure of the P. aeruginosa VgrG1 spike (PDB: 
4MTK) reveals the existence of a small C-terminal helix that folds along the VgrG β-helix. We 
therefore propose that additional C-terminal domains in VgrG and likely on PAAR proteins might be 
considered as internal adaptors for interaction with effectors and that the EAEC VgrG1 
DUF2345/TTR domain represents such a motif. Further experiments on different T6SS effectors will 
likely highlight the diversity of these selection modules. 
 
Experimental Procedures 
Bacterial strains, growth conditions and chemicals 
The E. coli strains and plasmids used in this study are listed in Supplemental Table S1. The entero-
aggregative E. coli EAEC strain 17-2 and its ∆T6SS-1, ∆tle1-tli1, ∆tli1-tli1b isogenic derivatives were 
used for this study. E. coli K-12 DH5α, W3110, BTH101, and T7-Iq pLys strains were used for 
cloning steps, co-immunoprecipitation, bacterial two-hybrid and protein purification respectively. The 
E. coli K-12 W3110 strain carrying the pUA66-rrnB plasmid (gfp under the control of the constitutive 
rrnB ribosomal promoter, specifying strong and constitutive fluorescence, and kanamycin resistance 
(Zaslaver et al., 2006)) was used as prey in antibacterial competition experiments. Strains were 
routinely grown in LB rich medium (or Terrific broth medium for protein purification) or in Sci-1 
inducing medium (SIM; M9 minimal medium, glycerol 0.2%, vitamin B1 1 µg/ml, casaminoacids 
100 µg/ml, LB 10%, supplemented or not with bactoagar 1.5%) with shaking at 37°C. Nematode 
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growth plates (NGM) were used for the C. elegans infection assay. Plasmids were maintained by the 
addition of ampicillin (100 µg/mL for E. coli K-12, 200 µg/mL for EAEC), kanamycin (50 µg/mL) or 
chloramphenicol (30 µg/mL). Expression of genes from pBAD, pOK12 and pASK-IBA vectors was 
induced at exponential phase for one hour with 0.1% of L-arabinose (Sigma-Aldrich), 100 µM of 
isopropyl--D-thio-galactopyrannoside (IPTG, Eurobio) and 0.1 µg/mL of anhydrotetracyclin (AHT, 
IBA Technologies) respectively. 5-bromo-4-chloro-3-indolyl--D-galactopyranoside (X-Gal, Eurobio) 
was used at 40 µg/mL. Globomycin (a kind gift of Dr. Danièle Cavard) was used at 50 µg/mL. 
Oligonucleotides and plasmids used in this study are listed in Supplemental Table S1.  
 
Strain construction 
The tle1 (EC042_4534) and tli1 (EC042_4535) genes were deleted into the EAEC 17-2 wild-type 
strain using a modified one-step inactivation procedure (Datsenko et al., 2000) as previously 
described (Aschtgen et al., 2008) using oligonucleotide pairs DEL-4534-5-DW/DEL-4534-3-DW. 
This oligonucleotide pairs carry 50-nucleotide 5’ extensions homologous to regions adjacent to tle1. 
Because tli1 is duplicated (tli1b has the same 5’ sequence than tli1), attempts to delete tle1 only 
yielded to the deletion of both tle1 and tli1 genes (∆tle1-tli1). The tli1 (EC042_4535) and tli1b 
(EC042_4536) genes were deleted into 17-2 wild-type strain as described above using oligonucleotide 
pairs DEL-4535-5-DW/DEL-4535-3-DW. Kanamycin resistant clones were selected and verified by 
colony-PCR. The kanamycin cassette was then excised using plasmid pCP20. The deletions of the 
gene of interest were confirmed by colony-PCR and complementation studies. 
 
Plasmid construction 
 23 
Custom oligonucleotides were synthesized by Sigma Aldrich and are listed in Supplemental Table S1. 
EAEC E. coli 17-2 chromosomal DNA was used as a template for all PCRs. E. coli strain DH5 was 
used for cloning procedures. Polymerase Chain Reactions (PCR) were performed using a Biometra 
thermocycler using the Q5 High fidelity DNA polymerase (New England Biolabs). All the plasmids 
(except pETG20A and pOK12 derivatives) have been constructed by restriction-free cloning (van den 
Ent and Löwe, 2006) as previously described (Aschtgen et al., 2010a). Briefly, genes of interest were 
amplified with oligonucleotides introducing extensions annealing to the target vector. The double-
stranded product of the first PCR has then been used as oligonucleotides for a second PCR using the 
target vector as template. For the pETG20A-Tle1 and pETG20A-Tli1 constructs, the genes encoding 
Tle1EAEC and signal sequence-less Tli1EAEC were amplified by PCR using specific Gateway® primers 
containing attB sequences, which allow insertion into the pDONR201 cloning vector by the BP 
recombination reaction, and then introduced into the pETG20A vector. The final constructs allow the 
production of Tle1EAEC or Tli1EAEC fused to an N-terminal hexahistidine-tagged thioredoxin (TRX) 
followed by a Tobacco etch virus (TEV) protease cleavage site. For pOK-TliHA, pOK-VgrGF, pOK-
VgrG1-573F and pOK-VgrG1-615F, the coding sequence of tli, vgrG and the different vgrG domains were 
amplified by PCR using oligonucleotides introducing EcoRI and XhoI restriction sites and cloned into 
the pOK12-derivative vector pMS600 (Aschtgen et al., 2008) digested by the same enzymes. In 
addition, the 3’ oligonucleotide contains the sequence encoding the FLAG epitope, allowing C-
terminal in-frame fusion of the vgrG derivatives with the FLAG epitope. The Ser197-to-Ala 
substitution was introduced in the pETG20A-Tle1, pBAD-Tle1-Tli1 and the pIBA-sp-Tle1 plasmids 
by QuickChange PCR-based targeted mutagenesis (Supplemental Table S1). Mutations were 
confirmed by DNA sequencing (GATC Biotech or Eurofins). 
 
 24 
Caenorhabditis elegans infection assay 
Virulence towards C. elegans was tested by a slow killing assay. L4 to adult stage nematods grown on 
E. coli OP50 were placed on unseeded NGM plates for 24 hours at 25°C. Twenty-five worms were 
then picked and placed onto lawns of bacteria to be tested. The viability of each individual was 
evaluated on a daily basis and the number of surviving nematods was plotted over time. The E. coli 
K-12 OP50 and B. cenocepacia K56-2 strains have been used as controls. 
 
Interbacterial competition assay 
The antibacterial growth competition assay was performed as described for the studies on the 
Citrobacter rodentium and EAEC Sci-2 T6SSs (Gueguen et al., 2013; Brunet et al., 2013) with 
modifications. The wild-type E. coli strain W3110 bearing the pUA66-rrnB plasmid (KanR (Zaslaver, 
2006)) was used as prey in the competition assay. The pUA66-rrnB plasmid provides a strong 
constitutive green fluorescent (GFP+) phenotype. Attacker and prey cells were grown for 16 hours in 
SIM medium, and then diluted in SIM to allow maximal expression of the sci-1 gene cluster (Brunet 
et al., 2011). Once the culture reached an OD600nm ~ 0.8, cells were harvested and normalized to an 
OD600nm of 10 in SIM. Attacker and prey cells were mixed to a 4:1 ratio and 20-µl drops of the 
mixture were spotted in triplicate onto a pre-warmed dry SIM agar plate supplemented or not with 
arabinose 0.02% or IPTG 20 µM. After 4-hour incubation of the plates at 37°C, fluorescent images 
were recorded with a LI-COR Odyssey imager. The bacterial spots were scratched off, and cells were 
resuspended in LB medium supplemented with chloramphenicol and normalized to an OD600nm of 0.5. 
Triplicates of 200 µl were transferred into wells of a black 96-well plate (Greiner) and the absorbance 
at 600 nm and fluorescence (excitation, 485 nm; emission, 530 nm) were measured with a Tecan 
Infinite M200 microplate reader. The relative fluorescence was expressed as the intensity of 
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fluorescence divided by the absorbance at 600 nm, after subtracting the values of a blank sample. 
These results are given in arbitrary units (AU) because the intensity of fluorescence is acquired with a 
variable gain and hence varies from one experiment to the other. For estimation of cfu, fluorescent 
KanR colonies were enumerated under UV light. The experiments were done in triplicate, with 
identical results, and we report here the results of a representative experiment. 
 
Computer algorithms for phylogenetic analyses and Tle1EAEC structure modelling 
Phylogenetic tree reconstruction has been made using Phylogeny.fr (Dereeper et al., 2008). The 
homology model of Tle1EAEC was built with Coot (Emsley et al., 2010) based on a Multalin alignment 
with the published P. aeruginosa effector Tle1PA (PDB: 4O5P, Hu et al., 2014). The regions present 
in Tle1EAEC but not in 4O5P were not included in the modelling. 
 
Bacterial two-hybrid assay (BACTH) 
The adenylate cyclase-based bacterial two-hybrid technique (Karimova et al., 1998) was used as 
previously published (Battesti and Bouveret, 2012). Briefly, pairs of proteins to be tested were fused 
to the isolated T18 and T25 catalytic domains of the Bordetella adenylate cyclase. After 
transformation of the two plasmids producing the fusion proteins into the reporter BTH101 strain, 
plates were incubated at 30°C for 48 hours. Three independent colonies for each transformation were 
inoculated into 600 µL of LB medium supplemented with ampicillin, kanamycin and IPTG (0.5 mM). 
After overnight growth at 30°C, 10 µL of each culture were dropped onto LB plates supplemented 
with ampicillin, kanamycin, IPTG and X-Gal and incubated for 16 hours at 30 °C. The experiments 
were done at least in triplicate and a representative result is shown. 
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Purification of Tle1, Tle1S197A and Tli1 
E. coli T7 Iq pLys cells carrying the pETG20A-Tle1, pETG20A-Tle1S197A or pETG20A-Tli1 
plasmids were grown at 37°C in terrific broth to an OD600 ~ 0.9 and tle1, tle1S197A or tli1 expression 
was induced with IPTG (0.5 mM) for 16 hours at 17°C. Cells were harvested by centrifugation and 
stored at -80C. The cell pellet was resuspended in Tris-HCl 20 mM pH 8.0, NaCl 300 mM, glycerol 
5% (v/v), lysozyme (0.25 mg/ml), DNase (2 µg/ml), MgSO4 20 mM, and phenylmethylsulfonyl 
fluoride (PMSF) 1 mM and cells were lysed by ultrasonication on ice. The insoluble material was 
discarded by centrifugation at 20,000 × g for 60 min at 4C. The soluble thioredoxin 6×His-tagged 
Tle1, Tle1S197A or Tli1 fusion proteins were purified by affinity chromatography on a nickel–
nitrilotriacetic acid resin (Bio-Rad) and the tag was removed after dialysis by overnight hydrolysis 
with the TEV protease and reloading in presence of 10 mM imidazole. The proteins were further 
purified by gel filtration chromatography (Superdex 75, 10/30 GE Healthcare) equilibrated in Tris-
HCl 20 mM pH 8.0, NaCl 300 mM, dithiothreitol (DTT) 2 mM using an AKTA purifier System 
(Amersham). The purified protein fractions were pooled and concentrated to ~15 mg/ml by 
ultrafiltration using the Amicon technology (Millipore, California, USA). For phopholipase activity 
assays, the purified Tle1 and Tle1S197A proteins were concentrated to 0.6 mg/mL.  
 
Purification of the Tle1EAEC-Tli1EAEC complex 
Purified Tle1EAEC and Tli EAEC were mixed together in a molar ratio of 1:1.2. The complex was 
purified by gel filtration chromatography (Superdex 75, 10/30 GE Healthcare) equilibrated in a Tris-
HCl 20 mM pH 8.0, NaCl 150 mM buffer using an AKTA purifier System (Amersham). The 
fractions containing the complex were pooled and concentrated to ~15 mg/mL as described above. 
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MALS/QELS/UV/RI-coupled size exclusion chromatography 
Size exclusion chromatography (SEC) was performed on an Alliance 2695 HPLC system (Waters) 
using a pre-calibrated KW802.5 column (Shodex) run in Hepes 25 mM pH 7.3, NaCl 250 mM at 0.5 
ml/min. MALS, UV spectrophotometry, QELS and RI were achieved with MiniDawn Treos (Wyatt 
Technology), a Photo Diode Array 2996 (Waters), a DynaPro (Wyatt Technology) and an Optilab 
rEX (Wyatt Technology), respectively, as described (Sciara et al., 2008). Mass and hydrodynamic 
radius calculation was done with ASTRA software (Wyatt Technology) using a dn/dc value of 0.185 
mL/g. 
 
Biolayer interferometry (BLI) 
The purified Tli1EAEC protein was first biotinylated using the EZ-Link NHS-PEG4-Biotin kit (Perbio 
Science, France). The reaction was stopped by removing the excess of biotin using a Zeba Spin 
Desalting column (Perbio Science, France). BLI studies were performed in black 96-well plates 
(Greiner) at 25°C using an OctetRed96 (ForteBio, USA). Streptavidin biosensor tips (ForteBio, USA) 
were first hydrated with 0.2 mL Kinetic Buffer (KB, ForteBio, USA) for 20 min and then loaded with 
biotinylated Tli1EAEC (10 g/mL in KB). The association of Tli1EAEC with various concentrations of 
Tle1 (0.4 nM, 1 nM, 2.56 nM, 6.4 nM, 16 nM and 40 nM) was monitored for 600 sec, and the 
dissociation was followed for 1,800 sec in KB. 
 
Phospholipase A1 and A2 fluorescent assays 
Phospholipase activities of Tle1EAEC and Tle1S197A were performed using fluorogenic phospholipid 
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substrates. Phospholipase A1 and A2 activities were monitored continuously using BODIPY® dye-
labeled phospholipids: PED-A1 (N-((6-(2,4-DNP)Amino)Hexanoyl)-1-(BODIPY® FL C5)-2-Hexyl-
sn-Glycero-3-Phosphoethanolamine) and red/green BODIPY® PC-A2 (1-O-(6-BODIPY-®558⁄568-
Aminohexyl)-2-BODIPY®FLC5-sn-Glycero-3-Phosphocholine), respectively (Darrow et al., 2011; 
Farber et al., 2001). The sn-2 fatty acyl group in PED-A1 is a non-hydrolyzable alkyl chain, and PED-
A1 substrate was used to specifically measure the PLA1 activity. The red/green BODIPY® PC-A2 has 
a sn-1 uncleavable alkyl chain. Substrate stock solutions (50 µM) were prepared in ethanol. All 
enzyme activities were assayed in Tris-HCl 10 mM pH 8.0, NaCl 150 mM, CaCl2 1 mM and Triton 
X-100 0.1%. Enzymatic reactions were performed at 20°C for 25 min in a final volume of 200 µL 
containing 20 µg of Tle1 purified protein (from a 0.6 mg.mL-1 stock solution) and 5 µM of the 
substrate. During pilot studies, we noted that concentrations of the purified Tle1 protein above 
1mg.mL-1 led to a decrease in the measured Tle1 PLA1 specific activity. The release of BODIPY® 
(BFCL5) (Life Technologies) was recorded at λexc = 485 nm and λem = 538 nm using a 96-well plate 
fluorometer (Fluoroskan ascent, Thermoscientific). Enzymatic activities were quantified using a 
BFCL5 calibration curve (0.08 - 200 pmoles in activity buffers) and expressed in pmol of fatty acid 
(or BFLC5) released per minute per mg of protein (pmol min‑1 mg-1). PLA1 from Thermomyces 
lanuginosus and Bee venom PLA2 (Sigma-Aldrich, Saint-Quentin Fallavier, France) were used as 
positive standards for PLA1 and PLA2 activities, respectively. Inhibition studies with Tli1EAEC were 
performed by incubating 20 µg of Tle1EAEC with various molar ratio of Tli1EAEC (xI=0.125, 0.25, 0.5, 
1 and 2). The residual activity was measured as described above. 
 
Activities on phospholipid monolayer films  
All experiments were performed using the KSV5000 system (KSV, Helsinki, Finland) equipped with 
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a Langmuir film balance to measure the surface pressure (Π) and monitored by the KSV Device 
Server Software v.3.50 running under Windows 7® as previously described (Point et al., 2013). A 
Teflon “zero-order” trough (Verger and de Haas, 1973) was filled with Tris-HCl 10 mM pH 8.0, NaCl 
100 mM, CaCl2 21 mM and EDTA 1 mM. The phospholipid monolayer was formed at the desired 
surface pressure (Π) of 20 mN.m-1 by spreading a few microliters of a phospholipid solution (1 
mg/mL in chloroform containing 0.4% v/v methanol) and further incubation for > 10 min (chloroform 
evaporation). Hydrolysis rate measurements were performed with a Teflon “zero-order” trough with 
two compartments: a reaction compartment (volume 43 mL; surface area, 38.5 cm2) and a reservoir 
compartment (volume 203 mL; surface area, 156.5 cm2) connected to each other by a small surface 
channel. The purified Tle1EAEC protein was injected into the subphase of the reaction compartment 
only (11 nM enzyme final concentration), whereas the phospholipid lipid film spread at the air-water 
interface covers both of them. When using medium chain phospholipids, such as DLPC, DLPG, 
DLPS or DLPE, soluble lipolysis products are released upon the action of phospholipase and a drop in 
surface pressure can be recorded. Using the barostat mode available on the KSV5000 instrument, an 
automatically driven Teflon mobile barrier can be moved over the reservoir to compress the 
phospholipid film and compensate for the substrate molecules removed from the film by the enzyme 
hydrolysis, thus keeping the surface pressure constant (here at Π = 20 mN.m-1). The kinetics of 
hydrolysis were recorded for at least 60 min and PLA activities (mol.cm‑2.min-1.M-1) were expressed 
as the number of moles of substrate hydrolyzed per time unit (min) and per surface unit (cm2) of the 
reaction compartment of the “zero-order” trough and for an arbitrary enzyme concentration of 1 M 
(de la Fournière et al., 1994). 
 
Globomycin treatment.  
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EAEC cells producing HA-tagged Tli1 from pOK- Tli1HA were grown to an optical density at 600 nm 
(OD600) of ~ 0.6 prior to the addition of 50 µg/mL of globomycin. After 10 min of treatment, IPTG 
was then added at a final concentration of 100 µM, and cells were further incubated for 30 min at 
37°C. Cells were harvested, and samples were analyzed by SDS-PAGE and immunoblotting. 
 
Escherichia coli K-12 toxicity assays 
Cells were grown in LB at 37°C for 16 hours. Bacterial suspensions were normalized to an OD600 of 2, 
serially diluted and 15 µL drops of each dilution were spotted onto selective LB agar plates 
containing or not arabinose 0.2%.  
 
Co-immunoprecipitation experiments 
One hundred mL of W3110 cells producing the proteins of interest from independent plasmids were 
grown to and OD600 ~ 0.4 and the expression of the cloned genes was induced with IPTG 200 µM or 
arabinose 0.2% for one hour. The cells were harvested and the pellets were frozen in liquid nitrogen 
and stored at -80°C for 1 hour. Pellets were then resuspended in Tris-HCl 20 mM pH 8.0, NaCl 100 
mM, sucrose 30%, lysozyme 100 µg/mL, EDTA 1 mM, DNase 100 µg/mL, RNase 100 µg/mL, 
Complete protease inhibitor cocktail (Roche) to an OD600 ~ 100 and incubated on ice for 15 min. An 
equal volume of Tris-HCl 20 mM pH 8.0, NaCl 100 mM, MgCl2 5 mM was then added, and the cells 
were lysed by two passages at the French Press (800 psi). Lysates were clarified by centrifugation at 
13,000 × g for 10 min. Supernatants were used for co-immunoprecipitation using Anti-FLAG® M2 
affinity gel (Sigma-Aldrich). After 3 hours of incubation, the beads were washed twice with 1 mL of 
Tris-HCl 20 mM pH 8.0, NaCl 100 mM, sucrose 15%, and once with Tris-HCl 20 mM pH 8.0, NaCl 
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100 mM. Beads were recovered and resuspended in 25 µL of SDS-loading buffer and heated for 10 
min at 96°C prior to SDS-PAGE and Western-blot analyses.  
 
Miscellaneous 
Fractionation, sedimentation sucrose gradient assays, NADH oxidase activity measurements and Hcp 
release assay have been performed as previously described (Aschtgen et al., 2008; Aschtgen et al., 
2010). SDS-Polyacrylamide gel electrophoresis was performed using standard protocols. For 
immunostaining, proteins were transferred onto 0.2 µm nitrocellulose membranes (Amersham 
Protran), and immunoblots were probed with primary antibodies (see below) and goat secondary 
antibodies coupled to alkaline phosphatase and developed in alkaline buffer in presence of 5-bromo-
4-chloro-3-indolylphosphate and nitroblue tetrazolium. The anti-TolB, anti-TolA, anti-OmpA and 
anti-OmpF polyclonal antibodies are from our laboratory collection, while the anti-HA (3F10 clone, 
Roche), anti-FLAG (M2 clone, Sigma Aldrich), anti-EF-Tu (Roche) and anti-VSVG (Sigma-Aldrich) 
monoclonal antibodies and alkaline phosphatase-conjugated goat anti-rabbit, mouse or rat secondary 
antibodies (Millipore) have been purchased as indicated. 
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Table 1. Rates of hydrolysis of DLPC, DLPE, DLPS and DLPG monolayers at a constant 
surface pressure of 20 mN m-1. 
 
Phospholipid 
Substrates 
enzyme activity 
(µmole cm-2 min-1 M-1) 
 Tle1 Tle1S197A 
Tle1 + Tli1 
(1:2 mol/mol) 
DLPC 148 (± 9)     no activity no activity 
DLPE 109 (± 5)     no activity no activity 
DLPS 97 (± 4)     no activity no activity 
DLPG no activity     no activity no activity 
 
 
Assays were carried out in a ‘zero order’ trough as described in the Experimental Procedures 
section. The final concentration of Tle1 and Tle1S197A was 11 nM for the lipolysis of each 
phospholipid. Enzyme activities are expressed as the number of moles of substrate hydrolyzed by 
time unit and surface unit of the reaction compartment of the “zero order” trough for an arbitrary 
lipase concentration of 1 M. All data are presented as mean values ± standard deviations of at least 
2 independent assays (CV% < 6%). Buffer: 10 mM Tris (pH 8.0), 100 mM NaCl, 21 mM CaCl2 
and 1 mM EDTA.  
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FIGURE LEGENDS 
 
Figure 1. The sci-1 T6SS gene cluster contributes to EAEC anti-bacterial activity. (A) The 
EAEC sci-1 T6SS is not required for virulence towards the C. elegans model of infection. The 
number of nematods surviving on lawn of the indicated strain (closed squares, E. coli OP50; closed 
circles, EAEC 17-2; open circles, EAEC ∆T6SS-1; closed triangles,  Burkholderia cenocepacia K56-
2) was plotted as percentage (% survival) over time (days). (B) Anti-bacterial assay. Prey cells 
(W3110 gfp+, kanR) were mixed with the indicated attacker cells, spotted onto sci-1-inducing medium 
(SIM) agar plates and incubated for 4 hours at 37°C. The image of a representative bacterial spot is 
shown and the relative fluorescent levels (in arbitrary unit, AU) are indicated in the upper graph. The 
number of recovered E. coli prey cells is indicated in the lower graph (in log10 of colony-forming 
units (cfu)). The circles indicate values from three independent assays, and the average is indicated by 
the bar. 
 
Figure 2. EC042_4534 phospholipase activity is responsible for Sci-1-mediated antibacterial 
activity. (A) Schematic representation of the EAEC 17-2 sci-1 T6SS gene cluster. The numbers on 
top refer to the genes locus tag (EC042_XXXX). Genes encoding core components (identified by 
their names on bottom) are colored grey. Genes of unknown function are indicated in white. The 
EC042_4534 gene encoding Tle1 is indicated in green whereas the two genes encoding the Tli1 and 
Tli1b immunity proteins are colored in blue. The asterisk below Tli1b indicates that a frameshift 
mutation on the 17-2 chromosome yields a truncated protein (Supplemental Fig. S2). (B) Homology-
based structural model of EC042_4534 based on the crystal structure of the P. aeruginosa Tle1PA 
effector (PDB: 4O5P). The magnification highlights the positions and orientations of the putative 
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catalytic triad amino-acid side chains (Ser-197, His-245 and Asp-310). (C) Specific phospholipase A1 
(PLA1) and A2 (PLA2) activity measurements of the EC042_4534 Tle1EAEC WT and S197A mutant 
proteins using fluorescent phospholipids. Specific activities were calculated from the velocity slope 
obtained for 25 minutes using 20 µg of purified protein. Data are expressed as mean values ± standard 
deviations of three independent assays (CV% < 5%). The SDS-PAGE analysis of the purified 
EC042_4534 (Tle1WT) and S197A (Tle1S197A) proteins (40 µg) after Coomassie blue staining is shown 
in the inset (molecular weight markers (in kDa) are indicated on the right). (D) EC042_4534 
(Tle1EAEC) phospholipase activity is responsible for Sci-1-mediated antibacterial activity. The anti-
bacterial activity was assessed by mixing W3110 gfp+ prey cells with the indicated attacker cells for 4 
hours at 37°C in sci-1-inducing medium containing 0.02 % arabinose (WT (EAEC 17-2), ∆T6SS-1 
(sci-1 gene cluster deletion derivative) and ∆tle1-tli1 (17-2 deleted of the tle1 and tli1 genes) carrying 
the pBAD18 empty vector, or ∆tle1-tli1 producing wild-type Tle1 (Tle1WT) and Tli1 or the S197A 
Tle1 mutant (Tle1S197A) and Tli1 from the pBAD18-Tle1-Tli1 or pBAD18-Tle1S197A-Tli1, 
respectively). The image of a representative bacterial colony is shown and the relative fluorescent 
levels (in arbitrary units, AU) are indicated in the upper graph. The number of recovered E. coli prey 
cells is indicated in the lower graph (in log10 of colony-forming units (cfu)). The circles indicate 
values from three independent assays, and the average is indicated by the bar. 
 
Figure 3. Tli1EAEC inhibits Tle1EAEC anti-bacterial phospholipase activity. (A) Anti-bacterial 
assay. The anti-bacterial activity was assessed by mixing W3110 gfp+ prey cells producing (pBAD-
Tli1EAEC) or not (pBAD18) the EC042_4535 (Tli1EAEC) protein from the pBAD promoter with the 
indicated attacker cells for 4 hours at 37°C in sci-1-inducing medium containing 0.02% arabinose. 
The image of a representative bacterial colony is shown and the relative fluorescent levels (in 
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arbitrary units, AU) are indicated in the upper graph. The number of recovered E. coli prey cells is 
indicated in the lower graph (in log10 of colony-forming units (cfu)). The circles indicate values from 
three independent assays, and the average is indicated by the bar. (B) The anti-bacterial activity was 
assessed by mixing ∆tli1-tli1b (17-2 deleted of the tli1 and tli1b genes) gfp+ prey cells producing 
(pBAD-Tli1EAEC) or not (pBAD18) the EC042_4535 (Tli1EAEC) protein from the pBAD promoter 
with the indicated attacker cells for 4 hours at 37°C in sci-1-inducing medium containing 0.02% 
arabinose. The image of a representative bacterial colony is shown and the relative fluorescent levels 
(in arbitrary units, AU) are indicated in the upper graph. The number of recovered E. coli prey cells is 
indicated in the lower graph (in log10 of colony-forming units (cfu)). The circles indicate values from 
three independent assays, and the average is indicated by the bar. (C) Tli1EAEC inhibition of Tle1EAEC 
PLA1 activity. The rate of hydrolysis of PED-A1 by purified Tle1EAEC at 20°C in presence of 
increasing concentrations of Tli1EAEC was plotted against the molar excess of Tli1EAEC. The SDS-
PAGE analysis of the purified Tli1EAEC (Tli1) protein after Coomassie blue staining is shown in the 
inset (molecular weight markers (in kDa) are indicated on the right). 
 
Figure 4. Tli1EAEC binds Tle1EAEC with nanomolar affinity. (A) Bacterial two-hybrid analysis. 
BTH101 reporter cells producing the indicated Tle1EAEC (Tle1) or Tli1EAEC (Tli1) proteins fused to 
the T18 or T25 domain of the Bordetella adenylate cyclase were spotted on X-Gal indicator plates. 
The blue color of the colony reflects the interaction between the two proteins. Controls include T18 
and T25 fusions to TolB and Pal, two proteins that interact but unrelated to the T6SS. (B) Gel 
filtration analysis on a calibrated Superdex 75 (10/30) column. The purified Tli1EAEC (left panel), 
Tle1EAEC (middle panel) proteins and the Tle1EAEC/Tli1EAEC mixture (right panel) were separated by 
gel filtration. Tli1EAEC, Tle1EAEC and the Tle1EAEC-Tli1EAEC complex eluted at 12.8 ml (~ 24 kDa), 
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10.37 ml (~ 66 kDa) and 9.8 ml (~ 82 kDa) respectively. The inset is the SDS-PAGE and Coomassie 
blue staining analysis of the fractions eluted after Tle1EAEC-Tli1EAEC complex separation. Peak 1 
contains the two proteins whereas peak 2 (13.1 ml) contains the excess of Tli1EAEC. The molecular 
weight markers (in kDa) are indicated on the right. (C) MALS/SEC/UV/RI analysis. The UV 
absorbance at 280 nm corresponding to Tli1EAEC (blue line), Tle1EAEC (orange line) and to the 
Tle1EAEC-Tli1EAEC complex (red line) was plotted against time (min. after sample injection in the High 
Performance Liquid Chromatography system). The traces indicating the molar mass (indicated on the 
left, in Da) are shown on each peak. (D) Bio-layer interferometry analysis. Recordings of the binding 
of purified Tle1EAEC (concentrations (in nM) indicated above the corresponding curve) to the 
streptavidin chip coupled to biotinylated Tli1EAEC. The response (in nm) is plotted versus the time (in 
sec.). The experimental association and dissociation curves (blue) are compared to the simulated ones 
(red). The calculated KD value is 1.50 ± 0.05 nM. 
 
Figure 5. Sub-cellular localizations of Tle1EAEC and Tli1EAEC. (A) Tle1EAEC is a cytoplasmic 
protein. Total ∆tle1-tli1 cells producing VSVG-tagged Tle1EAEC (Tle1VSVG) (T) were fractionated to 
isolate the periplasmic (P), cytoplasmic (C) and membrane fractions (M). Proteins from 109 (T, M) 
and 2×109 (P, C) cells were separated by SDS-PAGE and immunodetected with anti-VSVG 
monoclonal (Tle1VSVG), anti-EF-Tu (cytoplasmic marker), TolB (periplasmic marker), and TolA 
(membrane marker) antibodies. The position of the immunodetected proteins is indicated on the right. 
The molecular weight markers (in kDa) are indicated on the left. (B) Tli1EAEC bears a characteristic 
lipobox motif. ClustalW (T-Coffee) sequence alignment of the N-terminal region of the Tli1EAEC 
protein with that of representative homologous proteins (DUF2931 containing proteins) identified by 
HMMER analysis (Finn et al., 2011). The putative lipobox motif (L-[G/A/S]-[G/A/S]-C) is indicated 
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by a blue box. The position of the N-terminal cysteine residue of the processed form is underlined in 
green. (C) Tli1EAEC processing is dependent on signal peptidase II. EAEC ∆tli1-tli1b 2×109 cells 
producing HA-tagged Tli1EAEC (Tli1HA) treated (+) or not (-) with the signal peptidase II inhibitor 
antibiotic globomycin were subjected to SDS-PAGE and immunodetection with the anti-HA and anti-
OmpA antibodies. The unprocessed form of Tli1HA is indicated by an asterisk. The molecular weight 
markers (in kDa) are indicated on the left. (D) Tli1EAEC is an outer membrane protein. Total 
membrane from ∆tli1-tli1b cells producing FLAG-tagged Tli1EAEC (Tli1FL) were separated on a 
discontinuous sedimentation sucrose gradient. The collected fractions were subjected to 
measurements of the NADH oxidase activity (inner membrane marker, represented as relative % to 
the total activity) (upper graph) and to SDS-PAGE and immunodetection with the anti-OmpF (outer 
membrane marker), anti-TolA (inner membrane marker) and anti-FLAG antibodies. The positions of 
outer and inner membrane fractions (based on control markers) are indicated. 
 
Figure 6. Tle1EAEC periplasmic toxicity is counteracted by Tli1EAEC. (A) Cytoplasmic production 
of Tle1EAEC is not toxic. Serial dilutions (from 0 to 10-7) of normalized cultures of E. coli K-12 
W3110 cells producing the wild-type (Tle1WT) or the S197A mutant (Tle1S197A) Tle1EAEC proteins 
from the pBAD18 vector were spotted on LB agar plates supplemented (right panel) – or not (left 
panel) – with 0.2% arabinose. (B) Tli1EAEC protects the cell against the toxicity of the periplasmic 
production of Tle1EAEC. Serial dilutions (from 0 to 10-7) of normalized cultures of E. coli K-12 W3110 
cells producing Tli1EAEC from the pBAD33 vector and the maltose-binding protein (MBP), the wild-
type (Tle1WT) or the S197A mutant (Tle1S197A) proteins fused to a signal peptide (sp) from the pASK-
IBA4 vector (periplasmic targeting) were spotted on LB agar plates supplemented (right panel) – or 
not (left panel) – with 0.2% arabinose. 
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Figure 7. Tle1EAEC interacts with the VgrG1 C-terminal extension. (A) Tle1EAEC interacts with 
VgrG, not with Hcp or PAAR. BTH101 reporter cells producing Tle1EAEC fused to the T25 domain, 
and Hcp1, VgrG1 or PAAR proteins fused to the T18 domain of the Bordetella adenylate cyclase 
were spotted on X-Gal indicator plates. The blue color of the colony reflects the interaction between 
the two proteins. Controls include T18 and T25 fusions to TolB and Pal, two proteins that interact but 
unrelated to the T6SS. (B) The C-terminal domain of VgrG1 is required and necessary for Tle1EAEC 
co-immunoprecipitation. The soluble lysate from 1011 E. coli K-12 W3110 cells producing VSVG-
tagged Tle1EAEC (Tle1VS) alone (-, empty vector) or mixed with soluble lysates of W3110 cells 
producing the FLAG-tagged full-length (VgrGF) or variants of VgrG1 represented in panel (C) were 
immunoprecipitated on anti-FLAG-coupled beads. The immunoprecipitated material was subjected to 
12.5%-acrylamide SDS-PAGE and immunodetected with anti-FLAG (upper panel) and anti-VSVG 
(lower panel) monoclonal antibodies. Molecular weight markers (in kDa) are indicated on the left. 
The asterisks indicate the position of the antibody heavy chain. (C) Schematic representation of the 
EAEC VgrG1 protein and of the truncated variants used in this study. The different domains (and 
their boundaries) are indicated (gp27 and gp5 structural core; cc, coiled-coil; DUF, DUF2345; TTR, 
transthyretin-like region). (D) The TTR C-terminal region of VgrG1 is necessary and sufficient for 
the interaction with Tle1EAEC. BTH101 reporter cells producing Tle1EAEC fused to the T25 domain, 
and the indicated VgrG1 fragments fused to the T18 domain of the Bordetella adenylate cyclase were 
spotted on X-Gal indicator plates. The blue color of the colony reflects the interaction between the 
two proteins. Controls include T18 and T25 fusions to TolB and Pal, two proteins that interact but 
unrelated to the T6SS. 
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Figure 8. The VgrG1 CTD is required for antibacterial activity but not for T6SS assembly. (A) 
The VgrG1 CTD is required for Tle1-dependent killing. The anti-bacterial activity was assessed by 
mixing W3110 gfp+ prey cells with the indicated attacker cells: WT (EAEC 17-2), ∆T6SS-1 (sci-1 
gene cluster deletion derivative) and ∆vgrG (17-2 deleted of vgrG1 gene) carrying the pBAD18 and 
pMS600 empty vectors, or producing the indicated proteins (western-blot analyses shown in the inset), 
for 4 hours at 37°C in sci-1-inducing medium containing 0.02 % arabinose. The image of a 
representative bacterial colony is shown and the relative fluorescent levels (in arbitrary units, AU) are 
indicated in the upper graph. The number of recovered E. coli prey cells is indicated in the lower 
graph (in log10 of colony-forming units (cfu)). The circles indicate values from three independent 
assays, and the average is indicated by the bar. (B) The VgrG1 CTD is not required for proper 
assembly and function of the Sci-1 T6SS. Hcp release was assessed by separating whole cells (C) and 
supernatant (SN) fractions from WT (EAEC 17-2), ∆T6SS-1 (sci-1 gene cluster deletion derivative) 
and ∆vgrG1 (17-2 deleted of vgrG1 gene) carrying the pMS600 empty vector or producing the 
indicated VgrG1 variant, and pBAD-HcpVSVG. 1×108 total cells and the TCA-precipitated material 
from the supernatant of 2×108 cells were subjected to SDS-PAGE and immunodetection using anti-
VSVG monoclonal antibody (lower panel) and anti-TolB polyclonal antibodies as a lysis control 
(upper panel). The molecular weight markers (in kDa) are indicated on the left. 
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Strains 
 
 
Strains    Description and genotype        Source 
 
Enteroaggregative E. coli 
17-2 Wild-type enteroaggregative Escherichia coli Arlette Darfeuille-Michaud 
17-2 !tle1-tli1 17-2 deleted of the sci-1 tle1 and tli1 genes                                                                  This study 
17-2 !tli1-tli1b 17-2 deleted of the sci-1 tli1 and tli1b genes                                                                 This study 
17-2 !T6SS-1 17-2 deleted of the sci-1 gene cluster             This study 
17-2 !vgrG1 17-2 deleted of the sci-1 vgrG1 gene               (1) 
 
E. coli K12 
DH5!                                    F-, !(argF-lac)U169, phoA, supE44, !(lacZ)M15, relA, endA, thi, hsdR                                  Laboratory collection 
W3110                                   F-, lambda-IN(rrnD-rrnE)1 rph-1                                                                                                 Laboratory collection 
BTH101                                F-, cya99, araD139, galE15, gakK16, rpsL, hsdR, McrA1 McrB1                                                      (2) 
OP50 Wild-type strain used for C. elegans feeding        Steve Garvis 
 
Burkholderia cenocepacia  
K56-2 Wild-type isolate                 Carlos Gonzalez
      
 
  
Plasmids 
 
 
Vectors   Description              Source 
 
pCP20  FLP+, " cI857+, " pR Repts, AmpR, CmR                            (3) 
pETG20A                               Gateway® vector, 6-His-TRX followed by a TEV cleavage site, AmpR                                         Arie Geerlof 
pETG20A-Tle1                 sci-1 tle1 cloned upstream the TEV cleavage site into pETG20A                                                This study 
pETG20A-Tle1S197A               sci-1 tle1S197A cloned upstream the TEV cleavage site into pETG20A                                         This study 
pETG20A-Tli1              sci-1 signal sequence less tli1 (residues 20 to 225) cloned upstream the TEV site into pETG20A      This study                  
pASK-IBA37(+)                  Expression vector, AHT-inducible, AmpR                                   IBA technology 
pASK-IBA4                  Expression vector, AHT-inducible, OmpA signal sequence, Strep-tag, AmpR          IBA technology 
pMS600   pOK12, C-terminal HA epitope, KanR                                 (4) 
pOK-HcpHA         sci-1 hcp cloned into pOK12, C-terminal HA epitope, KanR                                 (5) 
pBAD18   pBR322 ori, pAra, AmpR                                      (6) 
pBAD33  pACYC-184 ori, pAra, CmR                                      (6) 
pEB354                                  pKT25 derivative, KanR, p15A, Plac, T25 domain of Bordetella adenylate cyclase                                       (7) 
pEB355                                  pUT18C derivative, AmpR, ColE1, Plac, T18 domain of Bordetella adenylate cyclase                                  (7) 
pBAD18-Tle1 sci-1 tle1 cloned into pBAD18, C-terminal VSVG epitope                      This study 
pBAD18-Tle1 S197A sci-1 tle1 S197A cloned into pBAD18, C-terminal VSVG epitope           This study 
pBAD18-Tle1-Tli1 sci-1 tle1and tli1 cloned in tandem into pBAD18, C-terminal VSVG epitope        This study 
pBAD18-Tle1 S197A -Tli1 sci-1 tle1 S197A and tli1 cloned in tandem into pBAD18, C-terminal VSVG epitope       This study 
pBAD18-Tli1EAEC sci-1 tli1 cloned into pBAD18, C-terminal VSVG epitope           This study 
pOK-TliHA   sci-1 tli cloned into pOK12, C-terminal HA epitope           This study 
pASK-IBA37-FLAG  FLAG epitope inserted into pASK-IBA37(+)            This study 
pASK-IBA37-Tli1FLAG          sci1 tli1 cloned into pASK-IBA37(+), C-terminal FLAG epitope                                     This study  
pBAD33-Tli1 sci-1 tli1 cloned into pBAD33, C-terminal VSVG epitope           This study 
pIBA-sp-MBP                   signal sequence less malE cloned into pASK-IBA4, N-ter Strep-tag, OmpA signal sequence             This study 
pIBA-sp-Tle1                   sci-1 tle1 cloned into pASK-IBA4, N-terminal Strep-tag epitope, OmpA signal sequence                  This study 
pIBA-sp-Tle1S197A              sci-1 tle1S197A cloned into pASK-IBA4, N-terminal Strep-tag epitope, OmpA signal sequence           This study 
pOK-VgrGFLAG  sci-1 vgrG cloned into pOK12, C-terminal FLAG epitope           This study 
pOK-VgrG(1-778)FLAG sci-1 vgrG residues 1 to 778 cloned into pOK12, C-terminal FLAG epitope        This study 
pOK-VgrG(1-615)FLAG sci-1 vgrG residues 1 to 615 cloned into pOK12, C-terminal FLAG epitope        This study 
pOK-VgrG(1-573)FLAG sci-1 vgrG residues 1 to 573 cloned into pOK12, C-terminal FLAG epitope        This study 
pT18-Pal                           pal cloned downstream T18 into pEB355                 (7) 
pTolB-T25                              tolB cloned upstream T25 into pEB354                (7) 
pT25-Tle1                 sci-1 tle1 cloned downstream T25 into pEB354                                                                             This study                                     
pT18-Tle1                          sci-1 tle1 cloned downstream T18 into pEB355                                                                           This study                                     
pTle1-T25                              sci-1 tle1 cloned upstream T25 into pEB354                                                                             This study                                   
pTli1 -T25                              sci-1 signal sequence less tli1 (residues 20 to 225) cloned upstream T25 into pEB354                       This study                                     
pTli1 -T18                              sci-1 signal sequence less tli1 (residues 20 to 225) cloned upstream T18 into pEB355                    This study                                  
pHcp1-T18                             sci-1 hcp cloned upstream T18 into pEB355              (8)  
pT18-Hcp1                            sci-1 hcp cloned downstream T18 into pEB355              (8) 
pT18-VgrG1                    sci-1 vgrG cloned downstream T18 into pEB355                                                    (8)  
pVgrG1 –T18                      sci-1 vgrG cloned upstream T18 into pEB355                                                        (8)                                      
pT18-PAAR                           sci-1 PAAR cloned downstream T18 into pEB355                This study                                  
pPAAR-T18                          sci-1 PAAR cloned upstream T18 into pEB355            This study                                  
pT18-VgrG1(1-778)             sci-1 vgrG residues 1 to 778 cloned downstream T18 into pEB355                                               This study 
pT18-VgrG1(1-615)   sci-1 vgrG residues 1 to 615 cloned downstream T18 into pEB355                                               This study 
pT18-VgrG1(1-573)   sci-1 vgrG residues 1 to 513 cloned downstream T18 into pEB355                                               This study                                    
pT18-VgrG1(771-841)       sci-1 vgrG residues 771 to 841 cloned downstream T18 into pEB355                                           This study                                    
pHcpFLAG                                                sci-1 hcp cloned into pUC12, C-terminal FLAG epitope                 (4) 
pBAD-HcpVSVG  sci-1 hcp cloned into pBAD18, C-terminal VSVG epitope               This study                                    
 
 
 
 
 
  
Oligonucleotides 
 
 
For mutant construction a  
    
17-2 !tle1-tli1     
DEL-4534-5/DW  GTAAAAGTTGAGTTTGGGAAGGTAAAAATTCATGGAGAAACAGAATGACATGTGTAGGCTGGAGCTGCTTCG 
DEL-4534-3/DW  GTGCGATAAAAATGATTTTATCTCTGGTCATGTATTGTCATCCTGTAGCGCATATGAATATCCTCCTTAGTTCC   
 
17-2 !tli1-tli1b     
DEL-4535-5/DW  GTAAAAAATACTAAAGTTATGATGTCTGGTGTTTAACGCTACAGGATGACAATACTGTGTAGGCTGGAGCTGCTTCG 
DEL-4535-3/DW  ATACAAAACCTTTAGACATAATACTCTCAAAAATAAATTTTCACTTTGAGCATATGAATATCCTCCTTAGTTCC     
 
17-2 !T6SS-1 
DEL-4524-5/DW  GGAGGCATCTGCGGTGATGGAACCCCTGAGATGCAGGTTT CACAGGAGAGAGCCTGTGTAGGCTGGAGCTGCTTCG 
DEL-4544-3/DW  TCCAGCCCGCCAGTGAAATTGCCATAGAGAATTTCATAAAGGGAAGGACGCGGCATATGAATATCCTCCTTAGTTC  
 
 
For plasmid construction b, c, d  
    
pETG20A-Tle1 
T6SS4534_p17Tev_F  GGGGACAAGTTTGTACAAAAAAGCAGGCTTAGAAAACCTGTACTTCCAGGGT ACAAAATATCAGGGATATGAC 
T6SS4534_p17_R  GGGGACCACTTTGTACAAGAAAGCTGGGTTTATTAAACACCAGACATCATAACTTTAG 
 
pBAD18-Tle1 
5pBAD-4534-VSVG      CTCTCTACTGTTTCTCCATACCCGTTTTTTTGGGCTAGCAGGAGGTATTACACCATGACAAAATATCAGGGATATG 
  ACGTA   
3pBAD-4534-VSVG  GGTCGACTCTAGAGGATCCCCGGGTACCTTATTTTCCTAATCTATTCATTTCAATATCTGTATAAACACCAGACAT 
CATAACTTTAG  
 
pBAD18-Tle1-Tli1 
5pBAD-4534-VSVG   CTCTCTACTGTTTCTCCATACCCGTTTTTTTGGGCTAGCAGGAGGTATTACACCATGACAAAATATCAGGGATATG 
ACGTA   
3pBAD-4535-VSVG  GGTCGACTCTAGAGGATCCCCGGGTACCTTATTTTCCTAATCTATTCATTTCAATATCTGTATACCAGTTACCGTAAGG 
ATAAG    
 
pBAD-Tli1EAEC (pBAD18-Tli1) and pBAD33-Tli1 
5pBAD-4535-VSVG  CTCTCTACTGTTTCTCCATACCCGTTTTTTTGGGCTAGCAGGAGGTATTACACCATGACCAGAGATAAAATCATTTT 
TATC   
3pBAD-4535-VSVG  GGTCGACTCTAGAGGATCCCCGGGTACCTTATTTTCCTAATCTATTCATTTCAATATCTGTATACCAGTTACCGTAAGG 
ATAAG    
 
pOK-TliHA   
5’EcoRI-4535  GTCGGAATTCACCAGAGATAAAATCATTTTTATCGCACC 
3’XhoI-4535  CTGCCTCGAGCCAGTTACCGTAAGGATAAGTTTTATCTCTG 
 
pASK-IBA37-FLAG    
pIBA37+FLAG-5  GAAGGAGATATACAAATGGCTAGCGGGGATTATAAGGACGACGATGACAAGTAAAGAGGATCGCATCACCATCACC   
pIBA37+FLAG-3  GCTAGCCATTTGTATATCTCCTTCTTAAAGTTAAACAAAATTTC 
 
pASK-IBA37-Tli1FLAG      
5-pIBA37-35  GTTTAACTTTAAGAAGGAGATATACAAATGACCAGAGATAAAATCATTTTTATCGC 
3-pIBA37-35  CGTCGTCCTTATAATCCCCGCTAGCCCAGTTACCGTAAGGATAAGTTTTATCTC 
 
pIBA-sp-MBP    
5-pIBA4-MBP   CCACCCGCAGTTCGAAAAAGGCGCCAAAATCGAAGAAGGTAAACTGGTAATC     
3-pIBA4-MBP   GAGCTCGAATTCGGGACCGCGGTCTCTTACTTGGTGATACGAGTCTGC  
   
pIBA-sp-Tle1                
IBA4-4534-5    CCACCCGCAGTTCGAAAAAGGCGCCACAAAATATCAGGGATATGACG 
IBA4-4534-3   GAGCTCGAATTCGGGACCGCGGTCTCTTAAACACCAGACATCATAACT 
 
pOK-VgrGFLAG 
EcoRI-4533-5   GTCGGAATTCAATCTCACTGACTCCCTGCAAAATGTTTTATC 
XhoI-4533-3   GATCCTCGAGTTACTTGTCATCGTCGTCCTTATAATCTTCTGTTTCTCCATGAATTTTTAC 
 
pOK-VgrG(1-778)FLAG 
EcoRI-4533-5    GTCGGAATTCAATCTCACTGACTCCCTGCAAAATGTTTTATC 
XhoI-4533delTTRFlag-3  GATCCTCGAGTTACTTGTCATCGTCGTCCTTATAATCCCCAAACCCTCGCGGCATTTC 
 
pOK-VgrG(1-615)FLAG 
EcoRI-4533-5    GTCGGAATTCAATCTCACTGACTCCCTGCAAAATGTTTTATC 
XhoI-4533DelDUFFlag  GATCCTCGAGTTACTTGTCATCGTCGTCCTTATAATCATTCAACCGTTGCTGACAAC 
 
pOK-VgrG(1-573)FLAG 
EcoRI-4533-5    GTCGGAATTCAATCTCACTGACTCCCTGCAAAATGTTTTATC 
XhoI-4533DelccDUFFlag  GCTACTCGAGTTACTTGTCATCGTCGTCCTTATAATCCTTTCCTTGTGCCTGAGGCTGC 
 
pT25-Tle1 
T25N-4534-5    GGCGGGCTGCAGATTATAAAGATGACGATGACAAGACAAAATATCAGGGATATGACG 
T25T18N-4534-3  CGAGGTCGACGGTATCGATAAGCTTGATATCGAATTCTAGTTAAACACCAGACATCATAACTTTAG 
 
pT18-Tle1 
T18N-4534-5  CGCCACTGCAGGGATTATAAAGATGACGATGACAAGACAAAATATCAGGGATATGACG 
T25T18N-4534-3  CGAGGTCGACGGTATCGATAAGCTTGATATCGAATTCTAGTTAAACACCAGACATCATAACTTTAG 
                         
pTle1-T25 
T25T18C-4534-5  CGGATAACAATTTCACACAGGAAACAGCTATGACCATGACAAAATATCAGGGATATGACG  
T25C-4534-3  GTTTGCGTAACCAGCCTGATGCGATTGCTGAACACCAGACATCATAACTTTAG   
  
pTli1-T25  
T25T18C-4535-5   CGGATAACAATTTCACACAGGAAACAGCTATGACCATGAATTCGGTTAGCTCACGGTATGC 
T25C-4535-3  GTTTGCGTAACCAGCCTGATGCGATTGCTGCCAGTTACCGTAAGGATAAGTTTTATCTC 
 
pTli1-T18    
T25T18C-4535-5   CGGATAACAATTTCACACAGGAAACAGCTATGACCATGAATTCGGTTAGCTCACGGTATGC                            
T18C-4535-3   CCTCGCTGGCGGCTAAGCTTGGCGTAATCCAGTTACCGTAAGGATAAGTTTTATCTC 
 
pT18-PAAR  
T18N-5-4537  CGCCACTGCAGGGATTATAAAGATGACGATGACAAGTCTAAAGGTTTTGTATTGCTTGGTG 
T25T18N-3-4537  CGAGGTCGACGGTATCGATAAGCTTGATATCGAATTCTAGTTATCCTATTGCACATTCCGGTG  
 
pPAAR-T18  
T25T18C-5-4537  CGGATAACAATTTCACACAGGAAACAGCTATGACCATGTCTAAAGGTTTTGTATTGCTTGGTG 
T18C-3-4537  CCTCGCTGGCGGCTAAGCTTGGCGTAATTCCTATTGCACATTCCGGTG 
   
pT18-VgrG1(1-778) 
T18N-4533-5   CGCCACTGCAGGGATTATAAAGATGACGATGACAAGAATCTCACTGACTCCCTGCAAAATGTTTTATCC  
T25T18N-4533delTTR-3  CGAGGTCGACGGTATCGATAAGCTTGATATCGAATTCTAGTTACCCAAACCCTCGCGGCATTTC 
 
pT18-VgrG1(1-615) 
T18N-4533-5   CGCCACTGCAGGGATTATAAAGATGACGATGACAAGAATCTCACTGACTCCCTGCAAAATGTTTTATCC  
T25T18N-4533delDUF-3  CGAGGTCGACGGTATCGATAAGCTTGATATCGAATTCTAGTTAATTCAACCGTTGCTGACAACTTATATCTC 
  
pT18-VgrG1(1-573) 
T18N-4533-5   CGCCACTGCAGGGATTATAAAGATGACGATGACAAGAATCTCACTGACTCCCTGCAAAATGTTTTATCC  
T25T18N-4533delCCDUF-3  CGAGGTCGACGGTATCGATAAGCTTGATATCGAATTCTAGTTACTTTCCTTGTGCCTGAGGCTG 
                                                                                 
pT18-VgrG1(771-841)  
T18N-4533-5   CGCCACTGCAGGGATTATAAAGATGACGATGACAAGAATCTCACTGACTCCCTGCAAAATGTTTTATCC  
T25T18N-4533delTTR-3  CGAGGTCGACGGTATCGATAAGCTTGATATCGAATTCTAGTTACCCAAACCCTCGCGGCATTTC 
 
pBAD18-HcpVSVG  
pBAD-Hcp1-5   CTCTCTACTGTTTCTCCATACCCGTTTTTTTGGGCTAGCAGGAGGTATTACACCATGGCAATTCCAGTTTATCTGTGG 
    CTG    
pBAD-Hcp1-VSVG-3  GGTCGACTCTAGAGGATCCCCGGGTACCTTATTTTCCTAATCTATTCATTTCAATATCTGTATACGCGGTGGTACGCTCAC 
    TCC 
 
 
For site-directed mutagenesis e  
    
A-4534S197A    GTTTGATGTTTTTGGTTTTgcCCGGGGAGCAGCGGCGGC  
B-4534S197A    GCCGCCGCTGCTCCCCGGgcAAAACCAAAAACATCAAAC 
 
 
a sequences corresponding to the downstream and upstream regions of the gene to be deleted underlined. 
b sequence annealing to the target vector underlined. 
c FLAG or VSVG tag coding sequence italicized. 
d restriction site in bold. 
e mutagenized bases in lower case  
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Figure S1. Tle1 and Tli1 are not necessary for T6SS assembly. Hcp release assay. Hcp release 
was assessed by separating whole cells (C) and supernatant (SN) fractions from EAEC 17-2 (WT), 
or its !sci-1 gene cluster (!T6SS-1) or !tle1-tli1 mutant derivative producing HcpHA (from the 
pOK-HcpHA plasmid). A total of 1"108 cells and the TCA-precipitated material from the supernatant 
of 2"108 cells were subjected to SDS-PAGE and immunodetection using anti-HA monoclonal 
antibody (lower panel) and anti-TolB polyclonal antibodies as a lysis control (upper panel). The 
molecular weight markers (in kDa) are indicated on the left.  
> EAEC 17-2 tli1b!
ATGACCAGAGATAAAATCATTTTTATCGCACCATTATTGGCATTGTTAACTGGGTGTAATTCGGTTAGCT
CACGGTATGCTGATTTGGATAAGACTGAATGGGGTTATAAAAAATTACCCTATGATGAATGGAAATTTCT
CTTTATTTATCCAAAGGCTCTGCCTGCGCTGGCCACCCAGGCGTTGATGGTGGACGGGGAAGGTTATAAG
ACGACTTATCAGTATCTTGATAATACCGAGCCGAGTCAGGTCAGTGTAGGGCGCTGGAATGACCATCTGG
GCGCGACTGAGTCGTATTATAACAAGGGGAAAGCATTACCCCTGATGTTGCGTTTTTGCTGGGATTCAAT
AATTGATAAAAAGAGTTATGAAACTCTGATTTTTTTAAAAAAGGGACCTGGGAGCAGATGGTTACGCCTT
ACGCAGACAACCGCTGGAACGAAACCTATTATCGTTCAACGATGATTATTGGTCTGGCTCCTGAAGGGAA
GGTAAGAGTCTGGCTGGGAGATCGCGGTAATCCGGTGGTACCTCAGTTGGATGCTAAAATTACTACAGTA
TCGGGTGATAAAATGAAGATGTGTAAGGGGGTTACTAAACATCCAGATGGATATGTTTATTACGGTGATA
CACCAGATTTTATCAAAGGGAAAATTTATCCCTACGGCAACTGGTGA!
B!
A!
Figure S2. The Tli1 proteins in EAEC strains. (A) Sequence alignment of the EC042 Tli1EAEC (EC042_4535), EC042 Tli1bEAEC 
(EC042_4536) and 17-2 Tli1b (17-2 EC042_4536) proteins. The conserved residues are white on a red background. The semi-
conserved residues are red, and the non-conserved residues are black. Figure prepared using MultAlin (9) and ESPript (
http://espript.ibcp.fr, (10)). The alignment highlights that the 17-2 Tli1b (17-2EC042_4536) protein is truncated (due to a frameshift 
mutation) whereas the 042 Tli1 and Tli1b proteins differ in their C-terminal regions. (B) Nucleotide sequence of the EAEC 17-2 tlib 
gene. The base preceding the frameshift is underlined and the premature stop codon resulting from frameshifting is indicated in red. 
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Figure S3. Tle1EAEC does not co-immunoprecipitate with Hcp1. Soluble lysates from 1011 E. coli 
K-12 W3110 cells producing VSVG-tagged Tle1 (Tle1VS) alone or mixed with soluble lysates of 
W3110 cells producing FLAG-tagged Hcp (HcpFL) were subjected to immunoprecipitation with 
anti-FLAG-coupled beads. The total soluble (Total) and the immunoprecipitated (IP) material were 
separated by 12.5%-acrylamide SDS-PAGE and immunodetected with anti-VSVG (upper panel) 
and anti-FLAG (lower panel) monoclonal antibodies. Molecular weight markers (in kDa) are 
indicated on the left.  
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Figure S4. Tle1EAEC clusters with T6SS phospholipases of the 
Tle1 family. Phylogenetic analyses of Tle1EAEC (EC042_4534; 
indicated by the arrow) with representative members of the 
Tle1-5 families identified by Russell et al., 2013. Each Tle 
family is represented by a color code. Figure prepared using 
Phylogeny.fr (Dereeper et al., 2008). 
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Figure S5. Tle1 family members bear a characteristic GXSRG motif. Sequence alignment of Tle1EAEC (EC042_4534) with 
representative members of Tle1 family identified by Russell et al., 2013. The alignment highlights the GXSXG motif (GFSRG) 
of the Tle1 family that is conserved in Tle1EAEC. The predicted S197, D245, and H310 residues of the catalytic triad are 
indicated by stars. Figure prepared using MultAlin (9). 
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